Effectiveness of Prolonged Use of IUD/Implant for Contraception
Completed · Not applicable
Conditions studied: Contraception
In brief
This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or having it removed and replaced with a new implant. Participants will be followed for up to three years.
Key facts
- Study ID
- NCT02267616
- Run by
- Indiana University
- People needed
- 1076
- Starts
- 2011-12-01
- Expected to finish
- 2021-03-31
- Last updated by the study team
- 2021-04-15
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women age 18-45
- Within 6 months of expiration or beyond the end of the FDA-approved duration of use of the levonorgestrel intrauterine device (LNG-IUD = 5 years) OR the etonogestrel-releasing subdermal implant (ENG implant = 3 years)
- Able to consent in English or Spanish.
- Not pregnant at the time of enrollment
You may not qualify if…
- Have history of female sterilization procedure
- Desire for conception in the next 12 months
- Not sexually active with a male partner
Where it is running
- Indiana University — Indianapolis, Indiana, United States
- Washington University in St. Louis School of Medicine — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.